EFFICACY AND SAFETY OF NIPOCALIMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: TOPLINE RESULTS FROM THE DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE 3 VIVACITY-MG3 STUDY

被引：0
作者：
Vu, Tuan
Antozzi, Carlo
Ramchandren, Sindhu
Nowak, Richard J.
Farmakidis, Constantine
Bril, Vera
De Bleecker, Jan
Yang, Huan
Minks, Eduard
Park, Jin-Sung
Grudniak, Mariusz
Smilowski, Marek
Sevilla, Teresa
Hoffmann, Sarah
Sivakumar, Kumaraswamy
Youssef, Eriene
Sanga, Panna
Karcher, Keith
Zhu, Yaowei
Ling, Leona
Sun, Hong
机构：
来源：
MUSCLE & NERVE | 2024年 / 70卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MG43
引用
收藏
页码：655 / 655
页数：1
相关论文
共 50 条
  • [21] Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)
    Sacca, Francesco
    Barnett, Carolina
    Vu, Tuan
    Peric, Stojan
    Phillips, Glenn A.
    Zhao, Sihui
    Qi, Cynthia Z.
    Gelinas, Deborah
    Chiroli, Silvia
    Verschuuren, Jan J. G. M.
    JOURNAL OF NEUROLOGY, 2023, 270 (04) : 2096 - 2105
  • [22] Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)
    Francesco Saccà
    Carolina Barnett
    Tuan Vu
    Stojan Peric
    Glenn A. Phillips
    Sihui Zhao
    Cynthia Z. Qi
    Deborah Gelinas
    Silvia Chiroli
    Jan J. G. M. Verschuuren
    Journal of Neurology, 2023, 270 : 2096 - 2105
  • [23] Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study
    Takeshima, Takao
    Sakai, Fumihiko
    Hirata, Koichi
    Imai, Noboru
    Matsumori, Yasuhiko
    Yoshida, Ryuji
    Peng, Cheng
    Cheng, Sunfa
    Mikol, Daniel D.
    HEADACHE, 2021, 61 (06): : 927 - 935
  • [24] Safety and efficacy of ataluren in nmDMD patients from Study 041, a phase 3, randomized, double-blind, placebo-controlled trial
    McDonald, C.
    Wu, S.
    Gulati, S.
    Komaki, H.
    Ruiz-Garcia, M.
    Kostera-Pruszczyk, A.
    Vlodavets, D.
    Chae, J.
    Jong, Y.
    Karachunski, P.
    Statland, J.
    Lorentzos, M.
    Penematsa, V
    Chou, C.
    Lin, M.
    Werner, C.
    Trifillis, P.
    Gordon, G.
    Klein, M.
    NEUROMUSCULAR DISORDERS, 2022, 32
  • [25] Safety and Efficacy of Ataluren in nmDMD Patients from Study 041, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
    McDonald, Craig M.
    Wu, Shiwen
    Gulati, Sheffali
    Komaki, Hirofumi
    Escobar, Rosa E.
    Kostera-Pruszczyk, Anna
    Vlodavets, Dmitry
    Chae, Jong-Hee
    Jong, Yuh-Jyh
    Karachunski, Peter
    Statland, Jeffrey
    Lorentzos, Michelle
    Penematsa, Vinay
    Chou, Connie
    Lin, Min
    Werner, Christian
    Trifillis, Panayiota
    Gordon, Gregory
    Koladicz, Karyn
    Mastrandrea, Nicholas
    Klein, Matthew
    NEUROLOGY, 2023, 100 (17)
  • [26] Randomized, Double-Blind, Placebo-Controlled, Crossover, Multicenter, Phase II Study of Eculizumab in Patients with Refractory Generalized Myasthenia Gravis (gMG)
    Howard, James
    Barohn, Richard
    Freimer, Miriam
    Juel, Vern
    Mozaffar, Tahseen
    Mellion, Michelle
    Benatar, Michael
    Farrugia, Maria
    Kissel, John
    NEUROLOGY, 2012, 78
  • [27] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER, MULTICENTER, PHASE II STUDY OF ECULIZUMAB IN PATIENTS WITH REFRACTORY GENERALIZED MYASTHENIA GRAVIS (GMG)
    Howard, J. F.
    Barohn, R.
    Cutter, G.
    Freimer, M.
    Juel, V.
    Mozaffar, T.
    Mellion, M.
    Benatar, M.
    Farragia, M.
    Pulley, M.
    Gorson, K.
    Chaudry, V.
    Pascuzzi, R.
    Siddiqi, Z.
    Kissell, J. T.
    MUSCLE & NERVE, 2011, 44 (04) : 689 - 690
  • [28] EFFICACY AND SAFETY OF INCOBOTULINUMTOXINA IN THE TREATMENT OF UPPER FACIAL LINES: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY
    Kerscher, Martina
    Rzany, Berthold
    Prager, Welf
    Trevidic, Patrick
    Inglefield, Christopher
    TOXICON, 2018, 156 : S60 - S60
  • [29] Efficacy and safety of adalimumab in Chinese patients with moderate to severe plaque psoriasis: Results from a phase 3, randomized, placebo-controlled, double-blind Study
    Zhang, Jianzhong
    Gu, Jun
    Zheng, Jie
    Zheng, Min
    Wang, Gang
    Gu, Yihua
    Okun, Martin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB232 - AB232
  • [30] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    JOURNAL OF PAIN, 2015, 16 (04) : S87 - S87
12345